Efficacy of venetoclax combined with hypomethylating agents in the treatment of patients newly diagnosed with core binding factor acute myeloid leukemia

导出

摘要 Objective To investigate the efficacy of venetoclax combined with hypomethylating agents(Ven-HMA),in patients with core binding factor acute myeloid leukemia(CBF-AML)intolerant to intensive induction therapy.Methods This study retrospectively analyzed patients newly diagnosed with CBF-AML who were aged<60 years and who received Ven-HMA as induction therapy at the Department of Hematology,the First Affiliated Hospital of Soochow University,between January 2020 and June 2023.

作者 HAN Siyi 韩思懿

机构地区 Natl Clin Res Center

出处《China Medical Abstracts(Internal Medicine)》 2025年第4期230-230,共1页 中国医学文摘(内科学分册英文版)

分类号 R733.71 [医药卫生—肿瘤]

引文网络
相关文献

1GAO Fan.Clinical characteristics and survival outcomes of patients with immunoglobulin A multiple myeloma in the bortezomib era:a single-center retrospective cohort study[J].China Medical Abstracts(Internal Medicine),2025,42(4):228-229.
2WANG Xin.Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes[J].China Medical Abstracts(Internal Medicine),2025,42(4):227-228.
3刘雨亭,耿素霞,杜欣.慢性粒单核细胞白血病治疗研究进展[J].循证医学,2026,26(1):57-62.
4WU Xingyue.Renal response and prognosis of newly diagnosed patients with multiple myeloma with renal impairment applying VRD and autologous hematopoietic stem cell transplantation[J].China Medical Abstracts(Internal Medicine),2025,42(4):229-230.
5Hongyan Liao,Feng Zhang,Fengyu Chen,Yifei Lid,Yanrui Sun,Darcee D.Sloboda,Qin Zheng,Binwu Ying,Tony Hu.Application of artificial intelligence in laboratory hematology:Advances,challenges,and prospects[J].Acta Pharmaceutica Sinica B,2025,15(11):5702-5733.
6Rabindranath Bera,Yotaro Ochi,Ying-Jung Huang,Ming-Chung Kuo,Kenichi Yoshida,Seishi Ogawa,Lee-Yung Shih.Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug Resistance[J].Oncology Research,2026,34(1):202-221.
7Ge Gao,Xiaoyu Sun,Jiajia Xu,Jian Yu,Yang Wang.miR-19-3p/GRSF1/COX1 axis attenuates early brain injury via maintaining mitochondrial function after subarachnoid haemorrhage[J].Stroke & Vascular Neurology,2025,10(3):297-310.
8Qi Tang,Yao Wu,Lin Chen,Qunying Jia,Yingchun He,Faqing Tang.A specific tsRNA in serum from patients with nasopharyngeal carcinoma: 5′tiRNA-32-ValAAC-2 mediates malignance of nasopharyngeal carcinoma cells[J].Frontiers of Medicine,2025,19(6):1194-1213.
9Jin Wang,Jiyin Wang,Yuting Zhang,Chaoyang Xiong,Shun-Ai Liu,Yaxian Kong,Jing Zhou,Xi Wang.Identifying vascular stiffening-sensitive macrophages through integration of single-cell transcriptomics and imaging flow cytometry[J].Biophysics Reports,2025,11(6):393-407.
10Feifei Tang,Yunqi Wang,Yu Zhang,Hongyu Zhang,Jinhai Ren,Pengcheng He,Yajing Xu,Hua Yan,Yongqian Jia,Liping Dou,Tao Wu,Zhi Guo,Xiaojun Yuan,Yongjun Fang,Xiaoyan Wu,Qian Jiang,Hao Jiang,Lanping Xu,Xiaohui Zhang,Xiaojun Huang.The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China[J].Science China(Life Sciences),2026,69(1):214-223. 被引量：1

China Medical Abstracts(Internal Medicine)

2025年第4期

浏览历史

内容加载中请稍等...

Efficacy of venetoclax combined with hypomethylating agents in the treatment of patients newly diagnosed with core binding factor acute myeloid leukemia

相关作者

相关机构

相关主题

浏览历史